임상 추론: 갑자기 발생한 기억력장애로 내원한 76세 여자

참고문헌 (13)

1. Cummings JL, "Vascular subcortical dementias : clinical aspects", Dementia, 5, pp.177~180 (1994)
2. Madureira S, "A follow-up study of cognitive impairment due to inferior capsular genu infarction", J Neurol, 246, pp.764~769 (1999)
3. Roman GC, "Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop", Neurology, 43, pp.250~260 (1993)
4. Sachdev P, "Diagnostic criteria for vascular cognitive disorders : a VASCOG statement", Alzheimer Dis Assoc Disord, 28, pp.206~218 (2014)
5. Skrobot OA, "The vascular impairment of cognition classification consensus study", Alzheimers Dement, 13, pp.624~633 (2017)
6. O'Brien JT, "Vascular dementia", Lancet, 386, pp.1698~1706 (2015)
7. Sinha K, "Current status and future prospects of pathophysiology-based neuroprotective drugs for the treatment of vascular dementia", Drug Discov Today (2020)
8. Court JA, "Neurotransmitter abnormalities in vascular dementia", Int Psychogeriatr, 15(Suppl 1), pp.81~87 (2003)
9. Wilkinson D, "Donepezil in vascular dementia : a randomized, placebo-controlled study", Neurology, 61, pp.479~486 (2003)
10. Auchus AP, "Galantamine treatment of vascular dementia : a randomized trial", Neurology, 69, pp.448~458 (2007)
11. Ballard C, "Efficacy, safety and tolerability of rivastigmine capsules in patients with probable vascular dementia : the VantagE study", Curr Med Res Opin, 24, pp.2561~2574 (2008)
12. Orgogozo JM, "Efficacy and safety of memantine in patients with mild to moderate vascular dementia : a randomized, placebo-controlled trial(MMM 300)", Stroke, 33, pp.1834~1839 (2002)
13. Wilcock G, "A double-blind, placebo-controlled multicentre study of memantine in mild to moderate vascular dementia (MMM500)", Int Clin Psychopharmacol, 17, pp.297~305 (2002)

관련 논문AI추천